Maratha Headlines

Seborrheic Dermatitis Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Arcutis Biotherapeutics, Cutanea Life Sciences, DermBiont, Astion Pharma A/S Amorepacific and Other

 Breaking News
  • No posts were found

Seborrheic Dermatitis Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Arcutis Biotherapeutics, Cutanea Life Sciences, DermBiont, Astion Pharma A/S Amorepacific and Other

April 15
22:09 2021
Seborrheic Dermatitis Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Arcutis Biotherapeutics, Cutanea Life Sciences, DermBiont, Astion Pharma A/S Amorepacific and Other

Seborrheic Dermatitis Pipeline

Seborrheic dermatitis is a chronic inflammatory dermatologic condition that usually affects the areas of the body with a large density of sebaceous glands, such as the scalp, face, chest, back, axilla, and groin. Overall, it has been reported to affect about 4% of the population. The cause of seborrheic dermatitis is not completely understood but it is thought to be triggered by the overgrowth of a harmless yeast called Malassezia that lives on the skin, or an overreaction by the skin’s immune system to this yeast. The diagnosis is based on the location and appearance of rash or lesion. Skin biopsy may be helpful but is rarely indicated. Seborrhoeic dermatitis is managed with treatment that reduces the level of skin yeast – these include creams and shampoo, which can be used safely on a long-term basis.

DelveInsight’s, Seborrhoeic Dermatitis Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Seborrhoeic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Request for free Sample Report: https://www.delveinsight.com/sample-request/seborrhoeic-dermatitis-pipeline-insight

 

Some of Seborrhoeic Dermatitis Companies are:

  • Arcutis Biotherapeutics
  • Cutanea Life Sciences
  • DermBiont
  • Astion Pharma A/S
  • Amorepacific
  • And Many Others

 

Request for free Sample Report: https://www.delveinsight.com/sample-request/seborrhoeic-dermatitis-pipeline-insight

 

Current Seborrhoeic Dermatitis Treatment Scenario and Seborrhoeic Dermatitis Emerging Therapies:

  • How many companies are developing Seborrhoeic Dermatitis drugs?
  • How many Seborrhoeic Dermatitis drugs are developed by each company?
  • How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Seborrhoeic Dermatitis?
  • What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Seborrhoeic Dermatitis therapeutics?
  • What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Seborrhoeic Dermatitis and their status?
  • What are the key designations that have been granted to the emerging drugs?

 

Some of Seborrhoeic Dermatitis Therapies are:

  • Topical roflumilast foam (ARQ-154)
  • Omiganan (CLS002)
  • DBI-002
  • PAC-14028
  • And Many Others

 

Request for free Sample Report: https://www.delveinsight.com/sample-request/seborrhoeic-dermatitis-pipeline-insight

 

Table of Contents:

Introduction

Executive Summary

Seborrhoeic Dermatitis: Overview

Pipeline Therapeutics

  • Comparative Analysis

Therapeutic Assessment

Seborrhoeic Dermatitis – DelveInsight’s Analytical Perspective

In-depth Commercial Assessment

Seborrhoeic Dermatitis Collaboration Deals

Late Stage Products (Phase III)

ASF 1057: Astion Pharma A/S

Drug profiles in the detailed report…..

Mid Stage Products (Phase II)

  • Comparative Analysis

ARQ-154: Arcutis Biotherapeutics

Drug profiles in the detailed report…..

Pre-clinical and Discovery Stage Products

DBI-002: Dermbiont

Drug profiles in the detailed report…..

Inactive Products

Seborrhoeic Dermatitis Key Companies

Seborrhoeic Dermatitis Key Products

Seborrhoeic Dermatitis- Unmet Needs

Seborrhoeic Dermatitis- Market Drivers and Barriers

Seborrhoeic Dermatitis- Future Perspectives and Conclusion

Seborrhoeic Dermatitis Analyst Views

Seborrhoeic Dermatitis Key Companies

Appendix

Request for Deatiled TOC: https://www.delveinsight.com/sample-request/seborrhoeic-dermatitis-pipeline-insight

 

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-pipeline-insight